The plaque psoriasis treatment market size was valued at USD 124.89 million in 2023, driven by the rising prevalence of the condition. The market size is anticipated to grow at a CAGR of 3% during the forecast period of 2024-2032 to achieve a value of USD 163.10 million by 2032.
Plaque Psoriasis Treatment: Introduction
Plaque psoriasis treatment aims to manage the chronic skin condition characterized by thick, red, and scaly patches (plaques). Therapies include topical treatments such as corticosteroids and vitamin D analogs, which are applied directly to affected areas. For more severe cases, systemic treatments like oral medications and biologic drugs are prescribed to target the immune system’s response. Light therapy (phototherapy) using ultraviolet light may also be recommended. Treatment plans are often personalized based on the individual’s condition and can involve a combination of therapies to reduce inflammation, alleviate symptoms, and improve the quality of life for patients.
Get a Free Sample Report with Table of Contents – https://www.expertmarketresearch.com/reports/plaque-psoriasis-treatment-market/requestsample
Key Trends in the Plaque Psoriasis Treatment Market
Biologic therapies have revolutionized plaque psoriasis treatment. They target specific immune system components responsible for the condition, leading to effective control of symptoms. The market is witnessing a surge in the development and adoption of biologics.
Novel oral systemic treatments have gained prominence, offering patients an alternative to injections or infusions. These medications provide convenience and expand treatment options. Innovative topical treatments, including creams and ointments, are emerging as effective solutions. They are designed to address psoriatic lesions and inflammation more efficiently while minimizing side effects.
The trend toward personalized treatment plans based on patients’ genetic and biological profiles is gaining traction. This approach ensures that individuals receive the most suitable treatment for their unique condition. Genetic testing is becoming more common in the assessment of psoriasis patients. By analyzing a patient’s genetic makeup, healthcare providers can identify specific genetic markers associated with the condition. This information helps determine the most suitable treatment options and predict an individual’s response to different therapies.
The integration of telehealth and remote monitoring technologies is becoming more widespread. It allows healthcare providers to monitor and consult with psoriasis patients, improving adherence to treatment plans and tracking disease progression. Psoriasis is often associated with other health issues like psoriatic arthritis, cardiovascular disease, and diabetes. The trend is to manage these comorbidities alongside psoriasis treatment to improve overall patient health.
The advent of biosimilars, which are cost-effective alternatives to biologic drugs, is increasing market competition and improving affordability and access to psoriasis treatment. The focus on patient-centered care is growing, with healthcare providers considering individual preferences, lifestyle, and quality of life when choosing treatment options. Shared decision-making is becoming a standard practice. Combining treatments such as biologics and topicals is gaining attention. These combination therapies offer improved efficacy and help reduce relapses.
Read Full Report with Table of Contents – https://www.expertmarketresearch.com/reports/psoriasis-treatment-market
Plaque Psoriasis Treatment Market Segmentation
Market Breakup by Diagnosis Method
- Blood Tests
- Skin Prick Test
- Patch Test
- Biopsy
- Others
Market Breakup by Treatment Type
- Biologics Drugs
- Apremilast
- Atanercept
- Infliximab
- Adalimumab
- Ustekinumab
- Secukinumab
- Ixekizumab
- Guselkumab
- Tildrakizumab
- Certolizumab
- Others
- Systemic Drugs
- Methotrexate
- Soriatane
- Otezla
- Sotyktu
- Cyclosporin
- Others
- Phototherapy
- Ultraviolet B (UVB)
- Topical Drugs
- Calcipotriene
- Tazarotene
- Calcineurin inhibitors
- Roflumilast
- Salicylic acid
- Others
- Others
Market Breakup by Therapy Type
- Monotherapy
- Combination Therapy
Market Breakup by Route of Administration
- Oral
- Tablets
- Capsules
- Parentals
- Intravenous
- Intramuscular
- Topicals
- Others
Market Breakup by Drug Type
- Over the Counter
- Prescription
- Branded
- Generics
Market Breakup by Population Type
- Childs
- Adults
- Male
- Female
- Geriatrics
- Male
- Female
Market Breakup by Treatment Channel
- Public
- Private
Market Breakup by End User
- Hospitals
- Specialty Clinics
- Homecare Settings
- Others
Market Breakup by Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
- Others
Market Breakup by Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Plaque Psoriasis Treatment Market Overview
The United States and Canada have a substantial market presence due to their advanced healthcare infrastructure and high prevalence of plaque psoriasis. Biologics and other advanced treatments are widely accessible in this region, and there is a focus on patient-centric care. Ongoing research and development activities in North America contribute to the introduction of new and innovative plaque psoriasis treatments.
European countries, including the United Kingdom, Germany, and France, maintain a strong foothold in the plaque psoriasis treatment market. These countries have well-established healthcare systems and robust pharmaceutical industries. Biologic therapies are popular, and there’s a strong emphasis on adherence to treatment guidelines.
Countries like China, India, and Japan are witnessing a growing demand for plaque psoriasis treatment due to increasing awareness and a rising prevalence of the condition. This region experiences a shift from traditional treatments to more advanced therapies, including biologics. The affordability and accessibility of treatments vary widely across Asia-Pacific, impacting market growth.
Each geographical region exhibits unique characteristics, driven by healthcare infrastructure, awareness, affordability, and regulatory factors. The global plaque psoriasis treatment market is influenced by these regional variations, reflecting the complex landscape of healthcare accessibility and treatment options for individuals with plaque psoriasis.
Plaque Psoriasis Treatment Market: Competitor Landscape
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
- Pfizer Inc.
- Abbvie Inc.
- Novartis AG
- Amgen Inc.
- Boehringer Ingelheim International GmbH.
- Merck & Co Inc.
- Sun Pharmaceutical Industries Ltd.
- Teva Pharmaceuticals Industries Ltd.
- AstraZeneca
- Ampio Pharmaceuticals Inc.
- Eli Lilly and Company
- Novartis International AG
- Sun Pharmaceuticals Industries Ltd.
- Stiefel Laboratories
- UCB S.A.
- LEO Pharma
- Cipla Inc.
- Rowan Bioceuticals
- Glenmark Pharmaceuticals
- Win-Medicare Pvt. Ltd.
- Sanofi S.A.
About Us:
Acquire unparalleled access to critical industry insights with our comprehensive market research reports, meticulously prepared by a team of seasoned experts. These reports are designed to equip decision-makers with an in-depth understanding of prevailing market trends, competitive landscapes, and growth opportunities.
Our high-quality, data-driven analyses provide the essential framework for organizations seeking to make informed and strategic decisions in an increasingly complex and rapidly evolving business environment. By investing in our market research reports, you can ensure your organization remains agile, proactive, and poised for success in today’s competitive market.
Don’t miss the opportunity to elevate your business intelligence and fortify your strategic planning. Secure your organization’s future success by acquiring one of our Expert Market Research reports today.
Media Contact:
Company Name: Claight Corporation
Contact Person: Joe Goldberg, Business Consultant
Email: sales@expertmarketresearch.com
Toll-Free Number: US +1-415-325-5166 | UK +44-702-402-5790
Address: 30 North Gould Street, Sheridan, WY 82801, USA
